1. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
    Kyoko Oura et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
  2. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
    Michele Barone et al, 2019, World Journal of Gastroenterology CrossRef
  3. Adjuvant Therapy for Hepatocellular Carcinoma after Curative Treatment
    Wen-Juei Jeng et al, 2014, Digestive Diseases CrossRef
  4. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
    Imogen M. Roth et al, 2019, Frontiers in Oncology CrossRef
  5. Systematic review with meta‐analysis: Branched‐chain amino acid supplementation in liver disease
    Anne M. van Dijk et al, 2023, European Journal of Clinical Investigation CrossRef
  6. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Fereshteh Asgharzadeh et al, 2020, Current Pharmaceutical Design CrossRef
  7. Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
    Antonio Facciorusso et al, 2020, Biomedicines CrossRef
  8. Local ablative treatments for hepatocellular carcinoma: An updated review
    Antonio Facciorusso et al, 2016, World Journal of Gastrointestinal Pharmacology and Therapeutics CrossRef